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IN 1959, Richmond described the carcinogenic effect of iron-dextran, injected
intramuscularly into rats. Since that time, there have been many accounts of
tumour induction by macromolecular iron-complexes in various experimental
animals (see Roe, 1967) and the neoplasms produced-predominantly sarcomas-
have often been described and illustrated. Much less attention has been paid to
the early stages of sarcoma development although several authors allude briefly
to changes which they have regarded as preneoplastic or neoplastic in character.
In his original account, Richmond noted that " occasional histiocytes develop
enlargement and hyperchromatism of the nucleus associated with mitotic activity
and other aberrant changes " and implied that injection-site sarcomas developed
from histiocytes-a view which has not been generally accepted. Muir and
Golberg (1961) described pale zones, visible to the naked eye, in which some of the
earliest stages of tumour development could be identified and similar abnormal
foci in the connective tissues were recorded by Lundin (1961) and Fielding (1962).
Roe, Haddow, Dukes and Mitchley (1964) described " sarcomata of microscopic
size" in injection sites from rats treated with iron-dextran, though they were
properly cautious in their evaluation of such lesions, and further examples were
briefly described by Roe and Carter (1967).
These changes are of more than academic interest as they occur in the sub-
cutaneous tissues of rats treated with a variety of carcinogens. Similar lesions
have been observed in rats injected with the rubber additive polymerised N-
nitroso-2,2,4-trimethyl-1,2,dihydroquinoline (NTDQ) (Carter, 1969) and in animals
bearing subcutaneous implants ofplastic sponges (Roe, Dukes and Mitchley, 1967);
it is also probable that the early neoplastic changes induced by implanted pellets
of polycyclic hydrocarbons such as 3,4-benzopyrene, 3-methylcholanthrene and
7,12-dimethylbenz(a)anthracene provide further examples of these lesions
(Rondoni, 1937; Orr, 1939; Stewart, 1939; also Vasilief, 1959; Vasiliefet al., 1962).
In the present paper, the early malignant changes induced by iron-dextran in the
rat are considered in detail.
MATERIALS AND METHODS
Ninety-five male CB Wistar rats, 5-8 weeks old, were divided into a test group
of 60 animals and a control group of 35 animals. The rats were housed in metal
cages, 6 animals in each, and maintained on a cubed diet (Dixon and Sons, Ware,
Herts.) and water ad libitum.
Iron-dextran (" imferon ": Fison's Pharmaceuticals Ltd., Holmes Chapel,
Cheshire) Batch No. 376/5 was used. 1 ml. of this preparation contains 50 mg.
iron.5. L. CARTER
Rats in the test group received once-weekly injections of 1 ml. iron-dextran
for 20 consecutive weeks, given intramuscuilarly into the right flank. The total
dose of iron administered to each rat was 1 g. The 35 rats in the control group
received 20 once-weekly intramuscular injections of 1 ml. physiological saline.
During and after their course of injections, all animals were regularly examined
and the injection-site carefully palpated.
It was originally intended that the rats, which were strictly randomised within
the two groups at the beginning of the experiment, should be killed in predeter-
mined pairs at 4-weekly intervals for a period of 72 weeks. Although satisfactory
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FIG. 1. Development of injection-site sarcomas in rats treated with iron-dextran.
in the early stages of the investigation, this scheme was eventually modified as
increasing numbers ofthe long-term survivors developed rapidly growing tumours
at the site of injection and had to be killed prematurely. The experiment was
therefore terminated at 64 weeks. The eventual times at which test and control
animals were killed are shown in Fig. 1.
Rats were killed with ether and full post-mortem examinations were made.
Injection sites from all test and control animals were excised and blocks of tissue
were removed from each end and from the middle of the injected region, together
with the liver, spleen, kidneys, pancreas, adrenal glands, lungs and any other
tissues showing macroscopic abnormalities. This material was fixed in Bouin's
solution and 5 gt paraffin sections were prepared and stained with haematoxylin
and eosin. Additional sections of the injection sites were stained with orcein and
Van Gieson, Masson's trichrome, Gordon and Sweets' silver impregnation method
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for reticulin fibres, Perl's method for iron, periodic acid-Schiff (PAS), toluidine
blue and Lison's alcian blue and chlorantine fast red.
RESULTS
It is clearly meaningless to analyse survival in an experiment where the
animals were, for the most part, killed at pre-determined intervals; but the times
at which rats in the test and control groups were killed are summarised in Fig. 1.
The large number of local neoplasms which developed towards the end of the
investigation vitiated the original plan for animals to be killed sequentially over
a longer span of time.
Tumours at the injection site were confined to rats which were treated with
iron-dextran. Twenty-five out of 60 test animals (41.7%) developed local sar-
comas-17 rats with macroscopic lesions only, 3 rats with macroscopic and
microscopic lesions, and 5 rats with microscopic lesions only. The first macro-
scopic sarcoma was recognised 31 weeks after the beginning of the experiment.
Once palpable through the indurated flank, the tumours grew rapidly and, in most
instances, the tumour-bearing rats had to be killed in the ensuing 20 to 30 days.
The average time of induction of the macroscopic sarcomas was 45 weeks. The
first microscopic sarcoma was seen at 33 weeks; although 3 of these lesions
occurred within the first 40 weeks, 5 were not encountered until later.
Histopathological Changes
I. Findings in rats injected with iron-dextran
(a) Injection sites
As several aspects of the developing tissue reaction to iron-dextran in rats
have already been described, notably by Baker, Golberg, Martin and Smith (1961),
the following account will deal mainly with those changes which are directly
associated with the early development of injection-site tumours. But in order
to set these findings in context, some comments will be made on the preceding
reactive changes induced by iron-dextran and also on the established sarcomas.
Non-neoplastic changes. Injection sites from rats killed after only 4 once-
weekly injections ofiron-dextran already contained large numbers ofmacrophages
which were heavily loaded with iron. Dermal blood vessels and nerves were
surrounded by siderophages and stainable iron often extended inside nerve
bundles, presumably taken up by Schwann cells. There were negligible amounts
of free extracellular iron. Moderate oedema was present but acute or chronic
inflammatory cells were rarely seen. As the number of injections increased, the
siderophages formed dense linear accumulations (Fig. 2), a striking feature
which was well developed by 8 weeks. By this time there was considerable de-
struction of muscle fibres, first in the panniculus carnosus, and later in the deeper
layers ofthe body wall. No evidence ofregeneration was seen and, as the muscles
were destroyed, there was an increasing amount of local fibrosis. Dense fibrous
tissue developed which tended to split the previously homogenous mass of sidero-
phages into smaller " islands " of cells (Fig. 3).
Apart from the very ealiest stages, therefore, the histological changes at the
injection site involve two principal elements-siderophages and fibrous tissue-
although the proportion of each tends to vary in different parts of the same
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injection site at any one time. It is against this background that neoplastic
changes develop.
Early or microscopic sarcomas. Nodules of atypical cells were seen in 8 rats
and were regarded as microscopic sarcomas. The first indication of impending
neoplastic change was the appearance of a " clear zone " between the previously
compact masses of siderophages and connective tissue. Such regions, too small
to recognise in gross specimens, were sharply demarcated and consisted of a few
atypical spindle-shaped cells in a mass of amorphous ground substance (Fig. 4).
Some of the cells were multi-nucleate and some in mitosis (Fig. 5). Their cyto-
plasm was PAS-positive and stained weakly with alcian blue; there was no intra-
cellular iron-pigment. The faintly eosinophilic ground substance was invariably
PAS-negative and, in most instances, showed weak metachromasia with toluidine
blue and some staining with alcian blue.
There was no limiting fibrous capsule but the connective tissues in and around
the foci of atypical cells showed striking changes (Fig. 6 and 7). The surrounding
structures contained a dense fibrous stroma but, in the region of the clear zones,
collagen and reticulin fibres were greatly reduced in amount and were fragmented;
fine fibres predominated but some fibres were unusually thick and coarse in
appearance. There was no morphological evidence of collagen formation by the
atypical cells in the nodules.
In some regions, the foci of abnormal cells were larger and appeared unequivo-
cally neoplastic. The cells were increased in number and commonly showed two
patterns of growth. In some injection sites, the proliferating cells remained
isolated and showed no tendency to become organised into a discrete lesion
(Fig. 8); in others, the tumour cells formed an almost solid core of neoplastic
EXPLANATION OF PLATES
FIG. 2. Injection site: 8 weeks. Dense accumulation of siderophages showing characteristic
orientatioin in long parallel lines. H. and E. x 120.
FIG. 3.-Injection site: 16 weeks. Siderophages interspersed with dense fibrous tissue. H. and
E. x 120.
FIG. 4.-Injection site: 37 weeks. Low-power view of a "clear zone " composed of a few
atypical spindle cells and ground substance, surrounded by siderophages and fibrous tissue.
PAS. x 120.
FIG. 5. Injection site: 40 weeks. Clear zone containing a number of pleomorphic spindle
cells, some of them in mitosis. PAS. x 120.
FIG. 6. Injection site: 46 weeks. Disruption and distortion of collagen fibres in a clear zone.
The surrounding stroma and siderophages can be seen but there is no connective tissue
capsule. Haematoxylin and Van Gieson. x 225.
FIG. 7. Injection site; 46 weeks. Same injection site showing distortion of reticulin fibres.
Silver impregnation (Gordon and Sweets). x 225.
FIG. 8.-Injection site; 46 weeks. Focal proliferation of spindle cells with no organisation
into a discrete " tumour ". H. and E. x 357.
FIG. 9. Injection site: 50 weeks. Well-established microscopic sarcoma composed of clumps
of pleomorphic cells (cf. Fig. 5). PAS x 120.
FIG. 10. Injection site: 50 weeks. An almost solid nodule of microscopic sarcoma which is
beginning to infiltrate between the adjacent siderophages. PAS x 120.
FIG. 11.-Injection site: 44 weeks. Typical spindle cell sarcoma, interspersed with a few
siderophages. H. and E. x 190.
FIG. 12. Injection site: 55 weeks. A more anaplastic tumour comprised of spindle cell and
pleomorphic elements. H. and E. x 225.
FIG. 13.-Injection site: 44 weeks. Malignant cells infiltrating between siderophages some
distance from the main tumour mass. H. and E. x 357.
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tissue (Fig. 9 and 10) though remnants of the clear zones still persisted. Large
pleomorphic foci of this kind sometimes showed irregular extensions into the
surrounding siderophages and connective tissues, suggesting that invasion, at
least on microscopical level, was beginning.
Macroscopic sarcomas. All of the 20 macroscopic tumours which developed
were sarcomas, comprising 16 spindle cell lesions and 4 mixed tumours with
spindle cells and a proportion of more pleomorphic elements (Fig. 11 and 12).
The spindle cell sarcomas showed variable amounts of collagen and all tumours
examined had a well-developed reticulin framework. None of them contained
stainable iron pigment. Regions of myxomatous degeneration were present in
some tumours, together with a few zones of haemorrhage and necrosis. No
metastases were seen but in most instances there was only a short interval between
the appearance of a palpable tumour and death of the animal.
Multiple tumours developed in several rats but detailed examination of
different parts of the injection-sites suggested that it is misleading to draw a
distinction between single and multiple injection-site sarcomas. Even in animals
with only one well-defined tumour, it was usually possible to demonstrate malig-
nant cells infiltrating between macrophages and fibrous tissue at some distance
from the main tumour (Fig. 13). Macroscopically, such regions were indurated
but showed no other features to suggest that they contained infiltrating tumour
cells.
(b) Other tissues
No tumours developed at other sites, but this possibly reflects the plan of the
experiment whereby rats were killed sequentially, beginning at an early stage in
the investigation.
Histological evidence ofiron-overloading in tissues other than the injection-site
was increasingly obvious during the later stages of the experiment. Kupffer
cells were usually laden with stainable iron at the first killing (after only 4 once-
weekly injections of iron-dextran) and increased numbers of siderophages were
seen in the splenic pulp. Later, stainable iron was demonstrated in littoral cells
in the deeper layers of the adrenal cortex, in the stromal tissues of the pancreas,
and in the renal tubular epithelium. Parenchymal structures in iron-laden tissues,
such as hepatocytes and exocrine and endocrine cells ofthe pancreas, occasionally
contained a trace of iron pigment.
In the later stages of the experiment, bronchiectasis and chronic cystic neph-
ritis became increasingly common but the incidence and degree of these changes
were similar to those found in normal Wistar rats maintained under conventional
conditions.
II. Findings in rats injected with physiological saline
Scanty infiltrates of inflammatory cells were seen in the injection sites during
the first few weeks but these soon disappeared, and dermal and epidermal struc-
tures remained normal for the rest ofthe experiment. No local fibrosis developed
in any animal.
One rat developed a generalised malignant lymphoma at 15 weeks, but no
other neoplasms were encountered. The incidence and severity of bronchiectasis
and chronic nephritis was similar to that previously observed in the test group.
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DISCUSSION
In the present investigation, the reactive changes encountered up to the stage
of development of local tumours resembled those recorded by Baker et al. (1961);
no new features emerged and these findings need not be discussed further. Simi-
larly, the 20 macroscopic sarcomas were comparable to those induced by previous
workers with iron-dextran. The absence of metastases has already been noted
but one fresh observation is the tendency for tumour cells to infiltrate throughout
the injection site, extending considerable distances from any obvious (seemingly
circumscribed) tumour mass. No rats developed local fibromas, confirming
previous views that benign injection-site neoplasms are more common with
smaller doses of iron-dextran (Roe et al., 1964; Roe and Carter, 1967); the very
large doses of iron-dextran used in the present experiment were, of course, de-
liberately chosen to favour the development of sarcomas.
The main purpose ofthis study was to describe the early morphological stages
oftumour development. The changes which have been found were consistent and,
although various alternative interpretations were considered for them, it seems
legitimate to regard such lesions as early or microscopic sarcomas (see below).
They are clearly different from the foci of normal fibroblastic proliferation which
appear during the first few weeks, usually following the local destruction of
muscle fibres (Baker et al., 1961). They can also be distinguished from regions of
myxomatous degeneration. The latter are rarely seen in injection sites which do
not contain a macroscopic tumour: they are larger, usually situated near zones of
haemorrhage or necrosis, and contain obvious pyknotic cell elements and poly-
morphs. The term " microscopic sarcoma " has been used in preference to
" presarcomatous nodule " which has been applied to similar lesions by Vasilief
and his colleagues (Vasilief, 1959; Vasilief et al., 1962). This is mainly because
of the difficulties in justifying the word " pre-sarcomatous " except in conditions
where the subsequent natural history of developing sarcomas is known in reason-
able detail and where " pre-sarcomatous " and " sarcomatous " phases can be
separated on both morphological and biological grounds.
The view that the foci of atypical spindle cells described here are indeed
microscopic sarcomas is strengthened by their striking similarity to the changes
produced in rats with other carcinogens, particularly the rubber additive NTDQ
(Carter, 1969). Both iron-dextran and NTDQ provoke lesions which appear to
originate as clear zones between accumulations of macrophages and consist of
abnormal spindle-shaped cells in a pool of amorphous ground substance. The
foci become progressively cellular and expand until, losing their initially circum-
scribed outline, they begin to extend into the surrounding tissues. It will be
noted that there is no tendency at any stage to develop a connective tissue capsule
or " pocket " comparable to that which forms round implanted plastics (cf.
Oppenheimer et al., 1958, 1964).
The yield of microscopic sarcomas was lower with iron-dextran than in the
earlier study with NTDQ-8 out of 60 rats, as opposed to 20 out of 40. But
NTDQ, despite its nitroso and quinoline moieties, is a weak carcinogen (Boyland,
Carter, Gorrod and Roe, 1968; Carter and Roe, 1968) and it can be postulated
that the tempo of malignant transformation with this compound is slow. By
contrast, large doses ofiron-dextran are strongly carcinogenic and the early stages
of sarcoma development are likely to be short-lived. One consequence of the
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small number ofmicroscopic sarcomas produced by iron-dextran is that it has not
been possible to demonstrate adequately whether such lesions are invariably the
fore-runners ofmacroscopic sarcomas. It was hoped that serial killing ofinjected
rats over a long period of time would establish that microscopic sarcomas were
more frequent during the earlier stages of the experiment. The present findings
(see Fig. 1) are equivocal: 3 of the 8 lesions were found within 40 weeks but the
remainder occurred later. A similar sequential study with the weaker carcinogen
NTDQ, recently begun, may resolve this question.
There is, then, evidence that a number of carcinogens induce the same dis-
tinctive changes in the subcutaneous tissues of the rat. On morphological
grounds, these may be regarded as microscopic sarcomas. Such studies do not,
however, provide information on the more detailed life-history ofthese foci: what
proportion of them grow progressively and develop into overt sarcomas? Con-
versely, do all macroscopic sarcomas originate from nodules ofthiskind? Detailed
investigation of these lesions is difficult as they are small and scattered in a
random fashion throughout the injection site, but further studies on their histo-
chemistry, together with electron microscopy and autoradiography, may clarify
some of these problems.
SUMMARY
Early stages in the development of sarcomas have been studied in 60 young
Wistar rats, treated with 20 once-weekly intramuscular injections ofiron-dextran.
Thirty-five control animals received 20 once-weekly intramuscular injections of
physiological saline. The rats were killed in pairs, mostly at 4-weekly intervals,
between the 4th and 64th weeks after the beginning of the experiment.
Twenty-five of the 60 test animals developed local sarcomas-17 rats with
macroscopic tumours only, 3 rats with macroscopic and microscopic sarcomas,
and 5 rats with microscopic lesions only. The microscopic lesions appeared first
as " clear zones " between dense accumulations of siderophages and consisted of
atypical spindle cells in a pool ofamorphous ground substance. Such foci became
progressively cellular and pleomorphic and eventually showed signs of extension
into the surrounding tissues. The macroscopic sarcomas produced were similar
to the spindle cell and pleomorphic neoplasms frequently reported in the past in
rats injected with iron-dextran.
Reasons for regarding these foci of atypical spindle cells as early sarcomas are
discussed and their close resemblance to lesions produced in the subcutaneous
tissues of the rat with a number of other carcinogens is emphasised.
I am indebted to Dr. F. J. C. Roe and Dr. Cuthbert Dukes for help with the
preparation of this account; to Miss Sylvia Adamthwaite, Mr. B. C. V. Mitchley
and Mr. E. Woollard for technical assistance; and to Mr. K. G. Moreman and the
staff of the Photographic Department, Chester Beatty Research Institute, for
preparing the photomicrographs.
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Institute, Institute of Cancer Research: Royal Cancer Hospital, from the Medical
Research Council, and the British Empire Cancer Campaign for Research.
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